top of page

Shared Visions: Embracing Progress with Retina Australia in their latest newsletter.


A snapshot from Retina Australia's December 2023 edition of the Retina Reporter.

I am delighted to be included in the December 2023 edition of Retina Australia’s biannual newsletter, the Retina Reporter. In this piece, Retina Australia share the remarkable strides we've made in our research journey, fuelled by their invaluable support. In 2018, a generous research grant of $39,591 ignited our exploration into using microRNA (miRNA) as a therapeutic avenue for retinal degenerations.

This initial grant became a catalyst, leading to five publications and leveraging nearly 50 times its value in subsequent funding. Thanks to the Australian National University and the National Health and Medical Research Council, we secured $1,969,692 to support the establishment of the Clear Vision Research Lab. Our lab, situated at ANU, is dedicated to pioneering diagnostics and treatments for conditions like Age-Related Macular Degeneration (AMD).

Our collaboration with Retina Australia goes beyond financial support. It provides us with the opportunity to connect with those at the heart of our research journey—the individuals grappling with retinal diseases. Listening to their stories fuels our sense of purpose, steering the trajectory of our day-to-day lab work. With this in mind, I am excited to share that I joined the Board of Directors of Retina Australia in October 2023, reinforcing our shared commitment to a vision we are passionately dedicated to.

Together, we are not just colleagues but collaborators, working towards a future where sight is unimpeded. Stay tuned as we continue this impactful journey, pushing the boundaries of vision research and bringing hope to those affected by retinal degenerations.




Comentários


bottom of page